Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $7.27 million. The enterprise value is -$287,336.
Important Dates
The next confirmed earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 3.67 million shares outstanding. The number of shares has increased by 85.46% in one year.
| Current Share Class | 3.67M |
| Shares Outstanding | 3.67M |
| Shares Change (YoY) | +85.46% |
| Shares Change (QoQ) | +33.37% |
| Owned by Insiders (%) | 3.50% |
| Owned by Institutions (%) | 6.68% |
| Float | 3.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.88 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.18
| Current Ratio | 3.18 |
| Quick Ratio | 3.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -270.80% and return on invested capital (ROIC) is -171.91%.
| Return on Equity (ROE) | -270.80% |
| Return on Assets (ROA) | -87.59% |
| Return on Invested Capital (ROIC) | -171.91% |
| Return on Capital Employed (ROCE) | -153.59% |
| Weighted Average Cost of Capital (WACC) | -6.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.99M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.42% in the last 52 weeks. The beta is -1.92, so ACXP's price volatility has been lower than the market average.
| Beta (5Y) | -1.92 |
| 52-Week Price Change | -74.42% |
| 50-Day Moving Average | 2.97 |
| 200-Day Moving Average | 4.27 |
| Relative Strength Index (RSI) | 36.58 |
| Average Volume (20 Days) | 194,418 |
Short Selling Information
The latest short interest is 102,286, so 2.79% of the outstanding shares have been sold short.
| Short Interest | 102,286 |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 2.79% |
| Short % of Float | 2.89% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.09M |
| Pretax Income | -7.97M |
| Net Income | -7.97M |
| EBITDA | n/a |
| EBIT | -8.09M |
| Earnings Per Share (EPS) | -$5.32 |
Full Income Statement Balance Sheet
The company has $7.56 million in cash and n/a in debt, with a net cash position of $7.56 million or $2.06 per share.
| Cash & Cash Equivalents | 7.56M |
| Total Debt | n/a |
| Net Cash | 7.56M |
| Net Cash Per Share | $2.06 |
| Equity (Book Value) | 5.27M |
| Book Value Per Share | 2.24 |
| Working Capital | 5.27M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -6.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.46% |
| Shareholder Yield | -85.46% |
| Earnings Yield | -109.60% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ACXP is $95.50, which is 4,723.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $95.50 |
| Price Target Difference | 4,723.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 5, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |